Clinical Trials in Tennessee

Showing 10061-10080 of 20,239 trials

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

NCT00193219

This trial will evaluate the combination of modified infusional 5-fluorouracil/ leucovorin, oxaliplatin (FOLFOX6), bevacizumab, and cetuximab in patients with metastatic colorectal cancer. FOLFOX6 has proven to be a safe and effective regimen in first line treatment of advanced colorectal cancer. The role of epidermal growth factor (EGFR) inhibitors in an earlier treatment setting in combination with optimal chemotherapy regimens is an important emerging question.

Colon Cancer

SCRI Development Innovations, LLC36 participantsStarted Jul 2005

Evansville, Indiana, United States • Louisville, Kentucky, United States • Portland, Maine, United States +7 more locations

COMPLETEDPhase 329 miles

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

NCT03268005

The study compares 2 medicines for type 2 diabetes: fast-acting insulin aspart (a new medicine) and NovoRapid®/NovoLog® (a medicine doctors can already prescribe). Fast-acting insulin aspart will be tested to see how well it works and if it is safe. Participants will get either fast-acting insulin aspart or NovoRapid®/ NovoLog® - which treatment you get is decided by chance. Both medicines will be taken together with insulin degludec. Participants will need to take 1 injection 4 times every day (all insulins will be provided in pens). The study will last for about 8 months (34 weeks).

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S1,264 participantsStarted Sep 2017

Concord, California, United States • Fresno, California, United States • Fullerton, California, United States +164 more locations

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

Find Trials by Condition in Tennessee

Effect of Dietary Sodium Intake on Vascular Endothelium

A Study of CNSA-001 in Women With Diabetic Gastroparesis

Phase 4 IOP Signals Associated With ILUVIEN®

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

FARE Peanut SLIT and Early Tolerance Induction

Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

Comparative Bioavailability of Risperidone.

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis